Literature DB >> 11529919

Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART.

S Resino1, J Navarro, J M Bellón, D Gurbindo, J A León, M A Muñoz-Fernández.   

Abstract

The objective of this study was to investigate the relationship between peripheral blood CD4+ T cell subsets and routine viro-immunological markers in vertically HIV-1-infected children undergoing highly active antiretroviral therapy (HAART). CD4+ and CD8+ T cell subsets were examined by three-colour flow cytometry. Plasma viraemia was quantified by a standardized molecular assay. A negative correlation between the %CD4+ T cells and both viral load and the %CD8+ T cells was observed. A strong positive correlation between the %CD4 T cells and naïve, CD38+ and non-activated CD4+ T cell subsets was found, whereas the %CD4 T cells correlated negatively with the numbers of memory, activated and memory-activated CD4+ T cell subsets. Elevated percentages of CD8 T cells were associated with increased memory and CD4+ CD62L-T cell subsets, whereas the naïve and CD4+ HLA-DRCD38+ subsets negatively correlated with the CD8%. Co-expression of CD62L on memory CD4+ cells and high expression of HLA-DR (but not of CD38) were associated with high viral load. No association between viral load and naïve CD4+ T cells was observed. Specific CD4+ T cell subsets may be more informative than routine surrogate markers in defining the evolution of HIV infection and immune reconstitution in children.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11529919      PMCID: PMC1906129          DOI: 10.1046/j.1365-2249.2001.01612.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  The functionally distinct subpopulations of human CD4+ helper/inducer T lymphocytes defined by anti-CD45R antibodies derive sequentially from a differentiation pathway that is regulated by activation-dependent post-thymic differentiation.

Authors:  L T Clement; N Yamashita; A M Martin
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

2.  Correlation of viral load and CD8 T-lymphocytes with development of neurological manifestations in vertically HIV-1-infected infants. A prospective longitudinal study.

Authors:  D Gurbindo; S Resino; S Sánchez-Ramón; J A León; M A Muñoz-Fernández
Journal:  Neuropediatrics       Date:  1999-08       Impact factor: 1.947

3.  [Prognostic markers of progression to AIDS in infants vertically infected by human immunodeficiency virus type-1].

Authors:  S Resino; J M Bellón; D Gurbindo; J T Ramos; J Ruiz Contreras; M A Muñoz-Fernández
Journal:  Med Clin (Barc)       Date:  2000-11-04       Impact factor: 1.725

4.  CD7 expression distinguishes subsets of CD4(+) T cells with distinct functional properties and ability to support replication of HIV-1.

Authors:  D L Wallace; P M Matear; D C Davies; R Hicks; C Lebosse; J Eyeson; P C Beverley; A Vyakarnam
Journal:  Eur J Immunol       Date:  2000-02       Impact factor: 5.532

5.  Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses.

Authors:  K Luzuriaga; M McManus; M Catalina; S Mayack; M Sharkey; M Stevenson; J L Sullivan
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Predictive markers of clinical outcome in vertically HIV-1-infected infants. A prospective longitudinal study.

Authors:  S Resino; D Gurbindo; J M Cano; S Sanchez-Ramón; M A Muõz-Fernández
Journal:  Pediatr Res       Date:  2000-04       Impact factor: 3.756

7.  CD4+ and CD8+ T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients.

Authors:  J M Franco; J A León-Leal; M Leal; A Cano-Rodriguez; J A Pineda; J Macías; A Rubio; C Rey; B Sanchez; E Lissen
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

8.  Alterations in cytotoxic and phenotypic subsets of natural killer cells in acquired immune deficiency syndrome (AIDS).

Authors:  S Plaeger-Marshall; C A Spina; J V Giorgi; R Mitsuyasu; P Wolfe; M Gottlieb; G Beall
Journal:  J Clin Immunol       Date:  1987-01       Impact factor: 8.317

9.  Age-related changes in human lymphocyte subsets: progressive reduction of the CD4 CD45R (suppressor inducer) population.

Authors:  P De Paoli; S Battistin; G F Santini
Journal:  Clin Immunol Immunopathol       Date:  1988-09

10.  Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults.

Authors:  R E Walker; C S Carter; L Muul; V Natarajan; B R Herpin; S F Leitman; H G Klein; C A Mullen; J A Metcalf; M Baseler; J Falloon; R T Davey; J A Kovacs; M A Polis; H Masur; R M Blaese; H C Lane
Journal:  Nat Med       Date:  1998-07       Impact factor: 53.440

View more
  13 in total

1.  HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy.

Authors:  S Resino; I Galán; A Pérez; J A León; E Seoane; D Gurbindo; M Angeles Muñoz-Fernandez
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

2.  Highly active antiretroviral therapy restores in vitro mitogen and antigen-specific T-lymphocyte responses in HIV-1 perinatally infected children despite virological failure.

Authors:  M Peruzzi; C Azzari; L Galli; A Vierucci; M De Martino
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

3.  Characteristics of lymphocyte subsets in HIV-infected, long-term nonprogressor, and healthy Asian children through 12 years of age.

Authors:  Jintanat Ananworanich; Tanakorn Apornpong; Pope Kosalaraksa; Tanyathip Jaimulwong; Rawiwan Hansudewechakul; Chitsanu Pancharoen; Torsak Bunupuradah; Mom Chandara; Thanyawee Puthanakit; Chaiwat Ngampiyasakul; Jurai Wongsawat; Suparat Kanjanavanit; Wicharn Luesomboon; Phennapha Klangsinsirikul; Nicole Ngo-Giang-Huong; Stephen J Kerr; Sasiwimol Ubolyam; Tawan Mengthaisong; Rebecca S Gelman; Kovit Pattanapanyasat; Vonthanak Saphonn; Kiat Ruxrungtham; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2010-12       Impact factor: 10.793

4.  Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy.

Authors:  Patrícia A Brindeiro; Rodrigo M Brindeiro; Cláudio Mortensen; Kurt Hertogs; Veronique De Vroey; Norma P M Rubini; Fernando S Sion; Carlos A M De Sá; Deisy M Machado; Regina C M Succi; Amilcar Tanuri
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

5.  HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.

Authors:  E Papasavvas; L Azzoni; X Yin; Q Liu; J Joseph; A Mackiewicz; B Ross; K M Lynn; J M Jacobson; K Mounzer; J R Kostman; L J Montaner
Journal:  J Viral Hepat       Date:  2017-05-11       Impact factor: 3.728

6.  HIV type 1 viremia on ART is positively associated with polyclonal T cell proliferation in subjects with T cell IFN-gamma secretion levels comparable to those of uninfected subjects.

Authors:  Emmanouil Papasavvas; Elizabeth C Moore; Junwei Sun; Livio Azzoni; Maxwell Pistilli; Karam Mounzer; Jane Shull; Jay R Kostman; Luis J Montaner
Journal:  AIDS Res Hum Retroviruses       Date:  2008-09       Impact factor: 2.205

7.  Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markers.

Authors:  S Resino; M L Abad; J Navarro; J M Bellón; S Sánchez-Ramón; M Angeles Muñoz-Fernández
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

8.  Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children.

Authors:  Salvador Resino; Isabel Galán; José M Bellón; M Luisa Navarro; Juan Antonio León; M Angeles Muñoz-Fernandez
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

9.  Preserved immune system in long-term asymptomatic vertically HIV-1 infected children.

Authors:  S Resino; R Correa; J M Bellón; M A Muñoz-Fernández
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

10.  Changes in cellular immune activation and memory T-cell subsets in HIV-infected Zambian children receiving HAART.

Authors:  Kaitlin Rainwater-Lovett; Hope Nkamba; Mwangelwa Mubiana-Mbewe; Carolyn B Moore; Joseph Margolick; William J Moss
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-15       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.